Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Gaps in curricula emphasize a need for enhanced interprofessional training to improve patient care.
Pharmacists can help patients with diabetes save money.
Studies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Self-audits help onsite frontline pharmacy leaders and team members to assess compliance before an external surveyor enters their pharmacy to inspect medication use processes.
A diagnosis of Clostridioides difficile infection does not instantly require treatment, but new guidelines include recommendations for treatment when warranted.
Each therapy presents a different but effective treatment option.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Pharmacists can provide resources, monitor medications, and extend compassionate support to patients experiencing mental health challenge.
Panelists discuss how factors such as patient preferences, disease severity, organ-specific involvement, and adverse effect profiles influence the selection of second-line therapies for steroid-refractory chronic graft-vs-host disease (cGVHD) in the context of multiple FDA-approved agents.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring patients receive individualized, evidence-based care.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Precision oncology represents an evolution in therapeutic practice.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Targeted therapies have greatly improved patient outcomes over the past 20 years.
One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.